167 related articles for article (PubMed ID: 16307022)
1. MLL gene rearrangements have no direct impact on Ara-C sensitivity in infant acute lymphoblastic leukemia and childhood M4/M5 acute myeloid leukemia.
Stam RW; Hubeek I; den Boer ML; Buijs-Gladdines JG; Creutzig U; Kaspers GJ; Pieters R
Leukemia; 2006 Jan; 20(1):179-82. PubMed ID: 16307022
[No Abstract] [Full Text] [Related]
2. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.
Stam RW; den Boer ML; Meijerink JP; Ebus ME; Peters GJ; Noordhuis P; Janka-Schaub GE; Armstrong SA; Korsmeyer SJ; Pieters R
Blood; 2003 Feb; 101(4):1270-6. PubMed ID: 12406912
[TBL] [Abstract][Full Text] [Related]
3. ALL-1 gene rearrangements in acute myeloid leukemia: association with M4-M5 French-American-British classification subtypes and young age.
Cimino G; Rapanotti MC; Elia L; Biondi A; Fizzotti M; Testi AM; Tosti S; Croce CM; Canaani E; Mandelli F
Cancer Res; 1995 Apr; 55(8):1625-8. PubMed ID: 7712464
[TBL] [Abstract][Full Text] [Related]
4. In vitro drug-resistance profile in infant acute lymphoblastic leukemia in relation to age, MLL rearrangements and immunophenotype.
Ramakers-van Woerden NL; Beverloo HB; Veerman AJ; Camitta BM; Loonen AH; van Wering ER; Slater RM; Harbott J; den Boer ML; Ludwig WD; Haas OA; Janka-Schaub GE; Pieters R
Leukemia; 2004 Mar; 18(3):521-9. PubMed ID: 14712291
[TBL] [Abstract][Full Text] [Related]
5. Cytosine arabinoside-metabolizing enzyme genes are underexpressed in children with MLL gene-rearranged acute lymphoblastic leukemia.
Mata JF; Scrideli CA; Queiroz RP; Mori BO; Emerenciano M; Pombo-de-Oliveira MS; Tone LG
Braz J Med Biol Res; 2006 Nov; 39(11):1417-23. PubMed ID: 17146554
[TBL] [Abstract][Full Text] [Related]
6. MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations.
Kerstjens M; Driessen EM; Willekes M; Pinhanços SS; Schneider P; Pieters R; Stam RW
Oncotarget; 2017 Feb; 8(9):14835-14846. PubMed ID: 27588400
[TBL] [Abstract][Full Text] [Related]
7. Chemosensitivity is differentially regulated by the SDF-1/CXCR4 and SDF-1/CXCR7 axes in acute lymphoblastic leukemia with MLL gene rearrangements.
Ando N; Furuichi Y; Kasai S; Tamai M; Harama D; Kagami K; Abe M; Goi K; Inukai T; Sugita K
Leuk Res; 2018 Dec; 75():36-44. PubMed ID: 30453100
[TBL] [Abstract][Full Text] [Related]
8. Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Stam RW; Den Boer ML; Schneider P; de Boer J; Hagelstein J; Valsecchi MG; de Lorenzo P; Sallan SE; Brady HJ; Armstrong SA; Pieters R
Blood; 2010 Feb; 115(5):1018-25. PubMed ID: 19965632
[TBL] [Abstract][Full Text] [Related]
9. The potential of clofarabine in MLL-rearranged infant acute lymphoblastic leukaemia.
Stumpel DJ; Schneider P; Pieters R; Stam RW
Eur J Cancer; 2015 Sep; 51(14):2008-21. PubMed ID: 26188848
[TBL] [Abstract][Full Text] [Related]
10. Romidepsin enhances the efficacy of cytarabine
Cheung LC; Cruickshank MN; Hughes AM; Singh S; Chua GA; Ford J; Ferrari E; Oommen J; Malinge S; Lock RB; Kees UR; Kotecha RS
Haematologica; 2019 Jul; 104(7):e300-e303. PubMed ID: 30679330
[No Abstract] [Full Text] [Related]
11. MLL-Rearranged Acute Lymphoblastic Leukemia.
El Chaer F; Keng M; Ballen KK
Curr Hematol Malig Rep; 2020 Apr; 15(2):83-89. PubMed ID: 32350732
[TBL] [Abstract][Full Text] [Related]
12. Cellular drug sensitivity in MLL-rearranged childhood acute leukaemia is correlated to partner genes and cell lineage.
Palle J; Frost BM; Forestier E; Gustafsson G; Nygren P; Hellebostad M; Jonsson OG; Kanerva J; Schmiegelow K; Larsson R; Lönnerholm G;
Br J Haematol; 2005 Apr; 129(2):189-98. PubMed ID: 15813846
[TBL] [Abstract][Full Text] [Related]
13. Bilateral ovarian B-lineage lymphoblastic lymphoma with MLL gene rearrangement: a novel case in infancy.
Larish AM; Dolan M; Casey T; Perkins JL
J Pediatr Hematol Oncol; 2015 May; 37(4):e215-7. PubMed ID: 25493458
[TBL] [Abstract][Full Text] [Related]
14. An Infant With Congenital Leukemia Cutis and AML-M5 With MLL Gene Rearrangement.
Bayhan T; Çiki K; Tavil B; Gümrük F; Çetin M; Ünal Ş
J Pediatr Hematol Oncol; 2015 Oct; 37(7):566-7. PubMed ID: 26207776
[No Abstract] [Full Text] [Related]
15. Cooperation of MLL/AF10(OM-LZ) with PTPN11 activating mutation induced monocytic leukemia with a shorter latency in a mouse bone marrow transplantation model.
Fu JF; Liang ST; Huang YJ; Liang KH; Yen TH; Liang DC; Shih LY
Int J Cancer; 2017 Mar; 140(5):1159-1172. PubMed ID: 27859216
[TBL] [Abstract][Full Text] [Related]
16. Mature B-cell lymphoblastic leukemia with MLL rearrangement: an uncommon and distinct subset of childhood acute leukemia.
Blin N; Méchinaud F; Talmant P; Garand R; Boutard P; Dastugue N; McIntyre EA; Harousseau JL; Avet-Loiseau H
Leukemia; 2008 May; 22(5):1056-9. PubMed ID: 18007578
[No Abstract] [Full Text] [Related]
17. Complex and cryptic chromosomal rearrangements involving the MLL gene in acute leukemia: a study of 7 patients and review of the literature.
De Braekeleer E; Meyer C; Douet-Guilbert N; Morel F; Le Bris MJ; Berthou C; Arnaud B; Marschalek R; Férec C; De Braekeleer M
Blood Cells Mol Dis; 2010 Apr; 44(4):268-74. PubMed ID: 20206559
[TBL] [Abstract][Full Text] [Related]
18. MLL rearrangements impact outcome in HOXA-deregulated T-lineage acute lymphoblastic leukemia: a Children's Oncology Group Study.
Matlawska-Wasowska K; Kang H; Devidas M; Wen J; Harvey RC; Nickl CK; Ness SA; Rusch M; Li Y; Onozawa M; Martinez C; Wood BL; Asselin BL; Chen IM; Roberts KG; Baruchel A; Soulier J; Dombret H; Zhang J; Larson RS; Raetz EA; Carroll WL; Winick NJ; Aplan PD; Loh ML; Mullighan CG; Hunger SP; Heerema NA; Carroll AJ; Dunsmore KP; Winter SS
Leukemia; 2016 Sep; 30(9):1909-12. PubMed ID: 26952838
[No Abstract] [Full Text] [Related]
19. Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.
Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW
Leukemia; 2013 Apr; 27(5):1063-71. PubMed ID: 23334362
[TBL] [Abstract][Full Text] [Related]
20. Venetoclax responses of pediatric ALL xenografts reveal sensitivity of MLL-rearranged leukemia.
Khaw SL; Suryani S; Evans K; Richmond J; Robbins A; Kurmasheva RT; Billups CA; Erickson SW; Guo Y; Houghton PJ; Smith MA; Carol H; Roberts AW; Huang DC; Lock RB
Blood; 2016 Sep; 128(10):1382-95. PubMed ID: 27343252
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]